|
1
|
Smith MG, Hold GL, Tahara E and El-Omar
EM: Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gotoda T, Yanagisawa A, Sasako M, Ono H,
Nakanishi Y, Shimoda T and Kato Y: Incidence of lymph node
metastasis from early gastric cancer: Estimation with a large
number of cases at two large centers. Gastric Cancer. 3:219–225.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim SS, Ruiz VE, Carroll JD and Moss SF:
Helicobacter pylori in the pathogenesis of gastric cancer and
gastric lymphoma. Cancer Lett. 305:228–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moss SF and Sood S: Helicobacter pylori.
Curr Opin Infect Dis. 16:445–451. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tammer I, Brandt S, Hartig R, König W and
Backert S: Activation of Abl by Helicobacter pylori: A novel kinase
for CagA and crucial mediator of host cell scattering.
Gastroenterology. 132:1309–1319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murata-Kamiya N, Kurashima Y, Teishikata
Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM
Jr, Azuma T, et al: Helicobacter pylori CagA interacts with
E-cadherin and deregulates the β-catenin signal that promotes
intestinal transdifferentiation in gastric epithelial cells.
Oncogene. 26:4617–4626. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Vries AC, van Grieken NCT, Looman CWN,
Casparie MK, de Vries E, Meijer GA and Kuipers EJ: Gastric cancer
risk in patients with premalignant gastric lesions: A nationwide
cohort study in the Netherlands. Gastroenterology. 134:945–952.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thorpe LM, Yuzugullu H and Zhao JJ: PI3K
in cancer: Divergent roles of isoforms, modes of activation and
therapeutic targeting. Nat Rev Cancer. 15:7–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang J and Slingerland JM: Multiple roles
of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell
Cycle. 2:339–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hers I, Vincent EE and Tavaré JM: Akt
signalling in health and disease. Cell Signal. 23:1515–1527. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tabassam FH, Graham DY and Yamaoka Y:
Helicobacter pylori activate epidermal growth factor receptor- and
phosphatidylinositol 3-OH kinase-dependent Akt and glycogen
synthase kinase 3β phosphorylation. Cell Microbiol. 11:70–82. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oda I, Saito D, Tada M, Iishi H, Tanabe S,
Oyama T, Doi T, Otani Y, Fujisaki J, Ajioka Y, et al: A multicenter
retrospective study of endoscopic resection for early gastric
cancer. Gastric Cancer. 9:262–270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li W, Wang H, Kuang CY, Zhu JK, Yu Y, Qin
ZX, Liu J and Huang L: An essential role for the
Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the
proliferation of endothelial progenitor cells in vitro. Mol Cell
Biochem. 363:135–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kurup PA: Endosymbioticactinidicarchaeal
mediated warburg phenotype mediates human disease state. Adv Nat
Sci. 5:81–84. 2012.
|
|
15
|
Chappell WH, Steelman LS, Long JM, Kempf
RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone
P, et al: Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors:
Rationale and importance to inhibiting these pathways in human
health. Oncotarget. 2:135–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bitting RL and Armstrong AJ: Targeting the
PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.
Endocr Relat Cancer. 20:R83–R99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bayascas JR and Alessi DR: Regulation of
Akt/PKB Ser473 phosphorylation. Mol Cell. 18:143–145. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wong BCY, Lam SK, Wong WM, Chen JS, Zheng
TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, et al: China Gastric
Cancer Study Group: Helicobacter pylori eradication to prevent
gastric cancer in a high-risk region of China: A randomized
controlled trial. JAMA. 291:187–194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei J, Nagy TA, Vilgelm A, Zaika E, Ogden
SR, Romero-Gallo J, Piazuelo MB, Correa P, Washington MK, El-Rifai
W, et al: Regulation of p53 tumor suppressor by Helicobacter pylori
in gastric epithelial cells. Gastroenterology. 139:1333–1343. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu Y, Qiao L, Wang S, Rong SB, Meuillet
EJ, Berggren M, Gallegos A, Powis G and Kozikowski AP:
3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid
analogues and carbonate surrogates block PI3-K, Akt, and cancer
cell growth. J Med Chem. 43:3045–3051. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Page C, Lin HJ, Jin Y, Castle VP, Nunez G,
Huang M and Lin J: Overexpression of Akt/AKT can modulate
chemotherapy-induced apoptosis. Anticancer Res. 20A:1–416.
2000.
|
